Peru and its historic scientific advance: The birth of the first clone of a Peruvian Paso horse is achieved

Published Aug 18, 2024

Tridge summary

The National University Toribio Rodríguez de Mendoza in Peru has made history by cloning the first Peruvian Paso horse, a symbol of national culture. The foal, born after a 332-day gestation, is in good health and marks a significant advancement in Peruvian science, aligning the country with leading nations in cloning. The cloning was possible due to somatic cell nuclear transfer technology and involved collaboration with the Livestock and Biotechnology Research Institute and the Peruvian Paso Horse Breeders Association of Piura. This achievement follows Peru's 2017 cloning of a Jersey breed calf, marking progress in the preservation and improvement of notable animal genetics.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

In Amazonas, a region located in the Peruvian jungle, they achieved a historic advance for national science. The National University Toribio Rodríguez de Mendoza (UNTRM) brought into the world the first clone of the Peruvian Paso horse in the country. It was revealed that the cloned foal, born after 332 days of gestation by natural birth, is in perfect health conditions. This feat stands out not only for the complexity of the process, but also for its cultural relevance, given that the aforementioned specimen is an emblematic symbol of the national culture, known for its elegance and distinctive gait. Likewise, this action places the Peruvian scientific community on par with highly developed countries in this field, such as Australia, the United States, Spain, Argentina, Brazil, Italy and Colombia. According to the university's official website, the birth of the peculiar equine was thanks to the use of somatic cell nuclear transfer technology (cloning). Now, with it, the genetics ...
Source: Infobae

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.